Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T75476 | Target Info | |||
Target Name | Myeloid differentiation primary response protein MyD88 (MYD88) | ||||
Synonyms | MyD88 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | MYD88 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Target Name | TNF receptor-associated factor 6 (TRAF6) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF85; RING-type E3 ubiquitin transferase TRAF6; RING finger protein 85; Interleukin-1 signal transducer; E3 ubiquitin-protein ligase TRAF6 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [1] | |||
3 | Affinity Capture-Western | [2] | |||
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Target Name | Toll/interleukin-1 receptor domain-containing adapter (TIRAP) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Toll/interleukin-1 receptor domain-containing adapter protein; TIR domain-containing adapter protein; MyD88-2; MyD88 adapter-like protein; MAL; Adaptor protein Wyatt | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Protein-Fragment Complementation Assay | [5] | |||
4 | Protein-Fragment Complementation Assay | [6] | |||
5 | Yeast two hybrid | [3] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Toll-like receptor 4 (TLR4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TLR-4; HToll; CD284 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Protein-Fragment Complementation Assay | [8] | |||
3 | Reconstituted Complex | [9] | |||
Kinases | [+] 3 Kinases | + | |||
Interacting Target Name | IL-1 receptor-associated kinase 1 (IRAK1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRAK-1; IRAK; Interleukin-1 receptor-associated kinase 1 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [10] | |||
3 | Affinity Capture-Western | [11] | |||
4 | Affinity Capture-Western | [12] | |||
5 | Affinity Capture-Western | [13] | |||
6 | Affinity Capture-Western | [14] | |||
7 | Affinity Capture-Western | [15] | |||
8 | Affinity Capture-Western | [16] | |||
9 | Affinity Capture-Western | [17] | |||
10 | Affinity Capture-Western | [18] | |||
Interacting Target Name | Renal carcinoma antigen NY-REN-64 (IRAK-4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigenNYREN64; Renal carcinoma antigen NY-REN-64; NY-REN-64 antigen; IRAK-4; Interleukin-1 receptor-associated kinase 4; Interleukin1 receptorassociated kinase 4 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [1] | |||
3 | Affinity Capture-Western | [13] | |||
4 | Affinity Capture-Western | [17] | |||
5 | Protein-Fragment Complementation Assay | [8] | |||
6 | Yeast two hybrid | [14] | |||
7 | Yeast two hybrid | [19] | |||
8 | Yeast two hybrid | [20] | |||
Interacting Protein Name | Interleukin-1 receptor-associated kinase-like 2 (IRAK2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRAK.2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [15] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Protein Name | Interferon regulatory factor 7 (IRF7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRF.7H; IRF7A; IRF7B; IRF7C; IRF7H | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Affinity Capture-Western | [22] | |||
3 | Fluorescence Resonance Energy Transfer | [22] | |||
4 | Yeast two hybrid | [22] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Protein Name | Speckle-type POZ protein (SPOP) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BTBD32; TEF2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [23] | |||
2 | Affinity Capture-MS | [24] | |||
3 | Affinity Capture-Western | [25] | |||
4 | Yeast two hybrid | [26] | |||
5 | Yeast two hybrid | [25] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | A20-binding inhibitor of NF-B (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein activation and protects from inflammatory disease. Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):E998-1006. | ||||
REF 2 | UBE2O negatively regulates TRAF6-mediated NF-B activation by inhibiting TRAF6 polyubiquitination. Cell Res. 2013 Mar;23(3):366-77. | ||||
REF 3 | Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001 Sep 6;413(6851):78-83. | ||||
REF 4 | A Pseudomonas aeruginosaIR effector mediates immune evasion by targetingBAP1 and TLR adaptors. EMBO J. 2017 Jul 3;36(13):1869-1887. | ||||
REF 5 | MAPPIT analysis of TLR adaptor complexes. FEBS Lett. 2007 Feb 20;581(4):629-36. | ||||
REF 6 | Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site. J Cell Sci. 2010 Jan 15;123(Pt 2):256-65. | ||||
REF 7 | Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem. 2000 Nov 3;275(44):34035-40. | ||||
REF 8 | MAPPIT analysis of early Toll-like receptor signalling events. Immunol Lett. 2008 Mar 15;116(2):141-8. | ||||
REF 9 | Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J Immunol. 2003 Apr 1;170(7):3565-71. | ||||
REF 10 | Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011 Sep 23;35(3):426-40. | ||||
REF 11 | Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88. J Biol Chem. 2002 Jul 5;277(27):24169-79. | ||||
REF 12 | A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol Cell Biol. 2005 Aug;25(15):6521-32. | ||||
REF 13 | IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5567-72. | ||||
REF 14 | Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med. 2003 Jan 20;197(2):263-8. | ||||
REF 15 | IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem. 1999 Jul 2;274(27):19403-10. | ||||
REF 16 | Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells. Exp Hematol. 2007 Dec;35(12):1812-22. | ||||
REF 17 | Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol. 2007 Oct;82(4):801-10. | ||||
REF 18 | Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex format... J Leukoc Biol. 2006 Apr;79(4):867-75. | ||||
REF 19 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 20 | Widespread macromolecular interaction perturbations in human genetic disorders. Cell. 2015 Apr 23;161(3):647-660. | ||||
REF 21 | IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J Biol Chem. 2006 Apr 14;281(15):10073-80. | ||||
REF 22 | Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol. 2004 Oct;5(10):1061-8. | ||||
REF 23 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 24 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 25 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 26 | Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005 Oct 20;437(7062):1173-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.